JM

Jeffrey C. Miller

ST Sangamo Therapeutics: 49 patents #1 of 112Top 1%
SB Sangamo Biosciences: 37 patents #4 of 93Top 5%
DA Dow Agrosciences: 18 patents #93 of 1,183Top 8%
University Of Texas System: 3 patents #1,041 of 6,559Top 20%
University of California: 2 patents #4,561 of 18,278Top 25%
ID Itoki Design: 1 patents #3 of 4Top 75%
🗺 California: #2,837 of 386,348 inventorsTop 1%
Overall (All Time): #18,772 of 4,157,543Top 1%
88
Patents All Time

Issued Patents All Time

Showing 1–25 of 88 patents

Patent #TitleCo-InventorsDate
11920169 Compositions for linking DNA-binding domains and cleavage domains David Paschon, Edward J. Rebar 2024-03-05
11845965 Regulation of gene expression using engineered nucleases Edward J. Rebar 2023-12-19
11834686 Engineered target specific base editors Friedrich Fauser, Edward J. Rebar 2023-12-05
11827900 Engineered target specific nucleases Edward J. Rebar 2023-11-28
11723952 Methods and compositions for treating Huntington's Disease Edward J. Rebar, H. Steve Zhang 2023-08-15
11725218 Artificial nucleases comprising engineered cleavage half-domains Yannick Doyon 2023-08-15
11661612 DNA-binding proteins and uses thereof Philip D. Gregory, David Paschon, Edward J. Rebar, Siyuan Tan, Fyodor Urnov +1 more 2023-05-30
11634463 Methods and compositions for treating hemophilia David Paschon, Edward J. Rebar 2023-04-25
11608492 Compositions for linking DNA-binding domains and cleavage domains 2023-03-21
11492643 Methods and compositions for treatment of a genetic condition Gregory J. Cost, Philip D. Gregory, Dmitry Guschin, Michael C. Holmes, David Paschon +4 more 2022-11-08
11401512 Engineered target specific nucleases Russell DeKelver, Ivan Krivega, Lei Zhang 2022-08-02
11198883 Methods and compositions for integration of an exogenous sequence within the genome of plants W. Michael Ainley, Dmitry Y. Guschin, Matthew Hayden, Daniel Isenegger, John Mason +5 more 2021-12-14
11136599 Artifical nucleases comprising engineered cleavage half-domains Yannick Doyon 2021-10-05
11123443 Htt repressors and uses thereof Steven Froelich, David Paschon, Edward J. Rebar, Bryan Zeitler, H. Steve Zhang 2021-09-21
10975393 Engineered target specific nucleases Edward J. Rebar 2021-04-13
10968261 Methods and compositions for genome engineering David Paschon, Edward J. Rebar, Thomas Wechsler, Lei Zhang 2021-04-06
10961540 FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks Noel Cogan, John White Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg +5 more 2021-03-30
10857203 Methods and compositions for treating Huntington's disease Edward J. Rebar, H. Steve Zhang 2020-12-08
10858416 Methods and compositions for modification of a HLA locus Trevor Collingwood, Laurence J.N. COOPER, Philip D. Gregory, Michael C. Holmes, Edward J. Rebar +2 more 2020-12-08
10844389 FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks W. Michael Ainley, Steven R. Webb, Jayakumar P. Samuel, Dmitry Y. Guschin, Lei Zhang 2020-11-24
10822599 Compositions for linking DNA-binding domains and cleavage domains 2020-11-03
10724020 Compositions for linking DNA-binding domains and cleavage domains David Paschon, Edward J. Rebar 2020-07-28
10669551 Zinc finger nuclease-mediated homologous recombination Qihua C. Cai, William M. Ainley, Robbi J. Garrison, Joseph F. Petolino, Beth C. Rubin-Wilson +2 more 2020-06-02
10662434 Optimized non-canonical zinc finger proteins Qihua C. Cai, Vipula Shukla, Joseph F. Petolino, Lisa W. Baker, Robbi J. Garrison +5 more 2020-05-26
10640790 Artificial nucleases including engineered FokI cleavage half-domains Yannick Doyon 2020-05-05